Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...
News Medical on MSN
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...
In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...
AZoLifeSciences on MSN
New Cloaked CRISPR Technology Reveals Hidden Gene Targets for Cancer Metastasis
The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer research in mouse models with an immune system that is as natural as possible – ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
The CRISPR gene editing technique has had a dramatic influence on biomedical research, and has even been applied to a few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback